PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC

Preliminary results from phase I trial in Japanese patients

2014-11-21
(Press-News.org) Barcelona, Spain: In a second presentation looking at new ways of treating non-small cell lung cancer (NSCLC) that has both the EGFR and T790M mutations, researchers will tell the 26th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, that an oral drug called ASP8273 has caused tumour shrinkage in patients in a phase I clinical trial in Japan.

Mutations of the epidermal growth factor (EGFR) occur in about 30-35% of Asian patients with NSCLC (and in 10-15% of Caucasian patients). EGFR inhibitors called tyrosine kinase inhibitors (TKI) [2], such as erlotinib, gefitinib and afatinib, can be used to treat EGFR-mutated NSCLC. However, these patients will eventually develop resistance to EGFR TKI therapy, rendering their disease resistant to current treatments. A further mutation called T790M accounts for 60% of this acquired resistance.

ASP8273 is a new drug that inhibits the EGFR mutation and the T790M resistance mutation. Earlier research in mice had shown that it caused NSCLC to disappear completely, and so a phase I clinical trial was started in January 2014 to assess the drug's safety and efficacy in humans.

Twenty-four Japanese patients have enrolled so far to receive one of six levels of doses (25, 50, 100, 200, 400 and 600mg) once a day. A further seven patients have been enrolled into a second group to evaluate doses of 100mg, 200mg and 400mg a day (a dose escalation study), and the researchers are planning to enrol a total of 124 patients. Cancer had progressed in all the patients after prior treatment with EGFR TKI therapy, and most of them had the T790M mutation.

Dr Haruyasu Murakami, of the Shizuoka Cancer Center, Shizuoka, Japan, will tell the meeting: "Preliminary results from this study show a high overall response rate of 78%, with tumours shrinking in seven out of nine patients who had both the EGFR and T790M mutations. While the number of patients is still small, this response is comparable with two other drugs in development that target EGFR - CO-1689 and AZ-9291 - but ASP8273 has fewer safety concerns than these drugs."

The most common adverse reactions to ASP8273 were mild cases of diarrhoea (in half of the patients), nausea and vomiting (in a third of the patients). There were none of the severe respiratory complications, heart problems and high blood sugar levels that have occurred during the clinical trials of the other two drugs. One patient receiving 400mg a day suffered diarrhoea that was severe enough for the dose to be reduced. The four patients who received 600mg a day had dose-limiting toxicities including severe diarrhoea, colitis (inflammation of the colon) and cholangitis (infection of the bile duct). All the patients in the trial who had the T790M mutation remain in the trial without further progression of their disease.

"These data indicate that ASP8273 would be expected to have potential clinical benefits with fewer adverse side-effects compared to CO-1689 and AZ-9291," Dr Murakami will say.

The researchers are continuing to recruit patients to the phase I dose escalation study. "We expect a recommended dose for a phase II trial to be determined soon and then we will start recruiting patients with both EGFR and T790M mutations immediately in Japan and other Asian countries. At present we are observing partial responses in patients receiving the 100mg dose and they are tolerating it well," he will conclude.

Professor Jean-Charles Soria, chair of the scientific committee for the EORTC-NCI-AACR Symposium and chair of the Drug Development Department at Gustave Roussy Cancer campus, France, commented: "ASP8273 is the fourth EGFR-mutant specific kinase inhibitor in development for NSCLC patients with acquired resistance to EGFR inhibition related to appearance of the T790M mutation. Activity is clearly promising and toxicity is in line with the anticipated mechanism of action, but numbers are small and follow-up is quite immature at present."

INFORMATION:

[1] EORTC [European Organisation for Research and Treatment of Cancer, NCI [National Cancer Institute], AACR [American Association for Cancer Research].
[2] TKI (tyrosine kinase inhibitors) inhibit tyrosine kinases, which are enzymes that trigger the cancer-causing activity of the epidermal growth factor receptor (EGFR).



ELSE PRESS RELEASES FROM THIS DATE:

US policy that gives priority to prior organ donors who need a transplant is working

2014-11-21
Highlights Living organ donors who later need kidney transplants have much shorter waiting times, and they receive higher quality kidneys compared with similar people on the waiting list who were not organ donors. In 2010, a total of 16,900 kidney transplants took place in the U.S. Of those, only 6,278 were from living donors. Washington, DC (November 20, 2014) -- Prior organ donors who later need a kidney transplant experience brief waiting times and receive excellent quality kidneys, according to a study appearing in an upcoming issue of the Journal of the American ...

Exercise may improve physical function, lessen pain in patients with kidney disease

2014-11-21
Highlights A 12-week course of aerobic exercise improved physical function and quality of life in patients with advanced chronic kidney disease. The exercise program also decreased patients' pain. More than 20 million people in the United States have chronic kidney disease. Washington, DC (November 20, 2014) -- Simple yet structured exercise can significantly improve kidney disease patients' quality of life as well as decrease their pain, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The ...

Pain, magnet displacement in MRI in patients with cochlear implants

2014-11-20
Pain, discomfort and magnet displacement were documented in a small medical records review study of patients with cochlear implants (CIs) who underwent magnetic resonance imaging (MRI), according to a report published online by JAMA Otolaryngology-Head & Neck Surgery. A CI can help patients with severe to profound hearing loss and about 300,000 people worldwide have the device. However, undergoing MRI can pose concerns for patients with CI because of exposure of the internal magnet to a strong electromagnetic field. There have been previous reports of adverse events, ...

When vaccines are imperfect

2014-11-20
Philadelphia, PA--The control of certain childhood diseases is difficult, despite high vaccination coverage in many countries. One of the possible reasons for this is "imperfect vaccines," that is, vaccines that fail either due to "leakiness," lack of effectiveness on certain individuals in a population, or shorter duration of potency. In a paper publishing today in the SIAM Journal on Applied Mathematics, authors Felicia Magpantay, Maria Riolo, Matthieu Domenech de Celles, Aaron King, and Pejman Rohani use a mathematical model to determine the consequences of vaccine ...

New survey of employers about the health insurance market

2014-11-20
A new nationally representative survey of employers--the largest purchasers of health care in the country-- shows that most are unfamiliar with objective metrics of health plan quality information. The survey, conducted by The Associated Press-NORC Center for Public Affairs Research, also found that employers are looking to the Affordable Care Act (ACA) as they make significant decisions on the benefits they offer, with the costs of health plans as a key consideration. Funding for the survey was provided by the Robert Wood Johnson Foundation. "There appears to be a serious ...

Time-lapse photos and synched weather data unlock Antarctic secrets

2014-11-20
PROVIDENCE, R.I. [Brown University] -- In preparation for his upcoming fieldwork, Brown University research analyst Jay Dickson took 10,000 pictures of the inside of his freezer. He wasn't investigating disappearing food or making sure the light went off when he closed the door. Dickson was making sure his new camera and timer would function properly for long periods in sub-freezing temperatures. "Everything worked great in the freezer for five weeks," Dickson said, "so hopefully it will all work in the field." That camera's next stop: a remote Antarctic outpost, where ...

New study: Aggressive conifer removal benefits Sierra aspen

2014-11-20
Chester, CA-- A study just published by Point Blue Conservation Science shows the benefits of an aggressive approach to restoring Sierra Nevada aspen stands (Populus tremuloides). Most of the aspen stands that dotted the Sierra Nevada less than a century ago are gone or in poor health. Aspen stands can increase groundwater, enrich soils and support a higher diversity of plants and wildlife, relative to adjacent forest types. Keeping aspen stands as part of our forests is critical to maintaining a healthy Sierra Nevada forest ecosystem for people and wildlife. The ...

UC Irvine-Italian researchers create first inhibitor for enzyme linked to cancers

UC Irvine-Italian researchers create first inhibitor for enzyme linked to cancers
2014-11-20
Irvine, Calif., Nov. 20, 2014 -- Recent studies showing acid ceramidase (AC) to be upregulated in melanoma, lung and prostate cancers have made the enzyme a desired target for novel synthetic inhibitor compounds. This week in Angewandte Chemie, a top journal in chemistry, UC Irvine and Italian Institute of Technology scientists describe the very first class of AC inhibitors that may aid in the efficacy of chemotherapies. AC, which is encoded by the ASAH1 gene, plays an important role in the regulation of cell fate, setting the balance between pro-aging/death and pro-life ...

Cost of meeting basic needs rising faster than wages in Washington state

2014-11-20
A Washington family of four must spend 46 percent more on average to make ends meet today than 13 years ago, according to a new report from the University of Washington. The Self-Sufficiency Standard for Washington State 2014, released Thursday (Nov. 20), provides a sobering look at how much it costs individuals and families statewide to meet basic needs -- and how far short they're falling. The study found that Washington families with two adults, a preschooler and a school-aged child saw the costs of meeting their most basic requirements jump as much as 72 percent ...

Discovery sheds light on nuclear reactor fuel behavior during a severe event

2014-11-20
A new discovery about the atomic structure of uranium dioxide will help scientists select the best computational model to simulate severe nuclear reactor accidents. Using the Advanced Photon Source (APS), a Department of Energy (DOE) Office of Science User Facility, researchers from DOE's Argonne National Laboratory and Brookhaven National Laboratory, along with Materials Development, Inc., Stony Brook University, and Carnegie Institution of Washington, found that the atomic structure of uranium dioxide (UO2) changes significantly when it melts. UO2 is the primary ...

LAST 30 PRESS RELEASES:

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

Poor vascular health accelerates brain ageing

[Press-News.org] Results of new drug, ASP8273, show response in patients with treatment-resistant NSCLC
Preliminary results from phase I trial in Japanese patients